Gail Boudreaux
CIK 1287920 · President and CEO · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
UNH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
INDIANAPOLIS, IN 46204
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | President and CEO | 169,991 | $419.36 | $71.29M | -$13.59M | 8 | 2026-07-17 |
| TGT | Director | 12,192 | $148.23 | $1.81M | $0 | 6 | 2026-03-13 |
| Elevance Health, Inc. (ANTM) Delisted | President and CEO | 94,041 | $482.58 | $45.38M | $2.00M | 6 | 2022-03-03 |
| ZBH | Director | 2,095 | $96.52 | $202.2K | $250.0K | 41 | 2021-04-02 |
| ANTX | President and CEO | 11,104 | $3.65 | $40.5K | $0 | 1 | 2018-03-05 |
| XEL | Director | 1,780 | $77.78 | $138.4K | $50.0K | 29 | 2018-01-02 |
| NVAX | Director | 10,000 | $9.93 | $99.3K | $144.8K | 4 | 2017-03-20 |
| UNH | EVP & CEO, UnitedHealthcare | 184,731 | $409.76 | $75.70M | -$24.88M | 39 | 2014-09-25 |
| GENZ | Director | 5,000 | $37.11 | $185.6K | $0 | 6 | 2011-04-06 |
Recent Filings · Page 8 of 15
141 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-07 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2015-04-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2015-03-30 | XEL | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2014-12-29 | XEL | Grant (A) | — | $0 | EDGAR |
| 2014-10-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2014-09-30 | XEL | Grant (A) | — | $0 | EDGAR |
| 2014-09-25 | UNH | Grant (A) | +657 | $0 | EDGAR |
| 2014-07-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2014-03-26 | UNH | Grant (A) | +519 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.